UPCOMING SESSIONS in ET
Mon, Apr 20, 2026
10:00 – 11:00 PM UTC
Dr. Tanmeet Sethi - From Surviving to Thriving: Reclaiming Joy with Chronic Illness Tanmeet Sethi MD Click To Register
UPCOMING SESSIONS in ET
Mon, Apr 20, 2026 · 10:00 – 11:00 PM UTC
Dr. Tanmeet Sethi - From Surviving to Thriving: Reclaiming Joy with Chronic Illness
Tanmeet Sethi MD
Click To Register
View all sessions

Prospective Evaluation of Artificial Intelligence-enabled Screening for Transthyretin Amyloid Cardiomyopathy (ATTR-CM) (TRACE-AI Yale)

Published: Feb 10, 2026
Category
Clinical Trials and Research
Source
https://clinicaltrials.gov/study/NCT07398950

Study Overview

Brief Summary

The TRACE-AI Diagnostic Study will evaluate the performance of artificial intelligence (AI) models applied to electrocardiograms (AI-ECG) and echocardiograms (AI-Echo) to identify transthyretin amyloid cardiomyopathy (ATTR-CM) in adults with heart failure. Model performance will be validated through comparison with technetium-99m pyrophosphate (PYP) imaging results.